focus -WSS

focus

author：leisure time 2025-09-29 13:08:58 Page View：938

Editor’s note: A recording of the event is embedded below.

Several biosimilar versions of Humira, which for years has been the world’s best-selling medicine, entered the U.S. market over the past year. What has that meant for insurance coverage and the way drugmakers are marketing these medicines? Join leading experts to discuss the impact on the industry and patients.

Sponsor introduction

Thomas Newcomer, vice president and head of U.S. market access, Samsung Bioepis (sponsor)

Featured speakers

Chris M. Brown, president, McAteer
Michael Gonzales, independent health care consultant, Michael Gonzales, LLC; former national and regional account director, AbbVie
Fran Gregory, MBA, PharmD, vice president of emerging therapies, Cardinal Health
Ed Silverman, Pharmalot columnist, senior writer, STAT (moderator)

Sponsored By

Previous article： Mega Millions jackpot rises to record $1.55 billion for Tuesday's drawing
Next article： Drug repurposing or repositioning? The language matters

leisure time

Wildfire smoke exposes gaps in outdoor worker protections

ApersonwaitingforthesubwaywearsafilteredmaskassmokyhazefromwildfiresinCanadablanketsaneighborhoodinN

2 US Navy sailors arrested for allegedly spying for China

2:23TheWasp-classamphibiousassaultshipUSSEssex(LHD2)transitstheArabianGulfonOct.9,2015.U.S.NavyPhoto

Peter Hotez and the public health issue of online harassment

AdobeFather’sDayweekendwasanythingbutcalmonTwitter,whicheruptedasvaccineexpertPeterHotezwaschallenge

Nearly two

1:17FormerPresidentDonaldTrumparrivesatRonaldReaganWashingtonNationalAirport,Aug.3,2023,inArlington,